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Aim: The purpose of this work was to obtain, multiply and characterize the adult neural crest-derived multipotent stem cells from 
human hair follicle for their further clinical use. Materials and Methods: Adult neural crest-derived multipotent stem cells were 
obtained from human hair follicle by explant method and were expanded at large-scale up to a clinically significant number. The 
resulted cell cultures were examined by flow cytometry and immunocytochemical analysis. Their clonogenic potential, ability 
to self-renewal and directed multilineage differentiation were also investigated. Results: Cell cultures were obtained from explants 
of adult human hair follicles. Resulted cells according to morphological, phenotypic and functional criteria satisfied the definition 
of neural crest-derived multipotent stem cells. They had the phenotype Sox2+Sox10+Nestin+CD73+CD90+CD105+CD140a+CD
140b+CD146+CD166+CD271+CD349+ CD34-CD45-CD56-HLA-DR-, showed high clonogenic potential, ability to self-renewal 
and directed differentiation into the main derivatives of the neural crest: neurons, Schwann cells, adipocytes and osteoblasts. 
Conclusion: The possibility of a large-scale expansion of adult neural crest-derived multipotent stem cells up to 40–200·106 cells 
from minimal number of hair follicles with retention of their phenotype and functional properties are the significant step towards 
their translation into the clinical practice.
Key Words: regenerative medicine, neural crest, hair follicle, neural crest-derived multipotent stem cells, directed differentiation, 
large-scale expansion.
Regenerative medicine is a rapidly developing field 
that promises to significantly improve the quality of the 
clinical treatment and to develop the cure for incur-
able diseases and pathological conditions. The main 
tools of regenerative medicine are tissue engineering, 
cell therapy and gene therapy. Nowadays there are 
several tissue-engineering, cellular and gene medi-
cal products in the world, successfully passed clinical 
trials and emerged on the market [1]. Most methods 
of regenerative medicine are based on in vitro cultur-
ing of human stem, progenitor or differentiated cells 
to increase their number up to required for clinical use, 
as well for the genetic correction, modifications of their 
biological properties or to create 3D living equivalents 
of different tissues and organs. Despite the significant 
progress in the field of pluripotent stem cells (embry-
onic stem cells and induced pluripotent stem cells), 
a number of ethical and biosafety issues remain un-
resolved. Thus, the identification and characterization 
of new types of adult stem cells is an actual challenge. 
In addition, the medical use of in vitro cultured human 
cells requires the development of criteria for the safety 
and efficacy of cell-based medicinal products in terms 
of identity, purity and potency. For example, such 
criteria were developed for multipotent mesenchymal 
stem/stromal cells (MSCs) from bone marrow and 
adipose tissue [2, 3].
Adult neural crest-derived multipotent stem cells 
(NC-MSCs) for a number of reasons are a promising 
cell type for regenerative medicine applications [4]. 
During the embryonic development, neural crest cells 
generate a wide variety of cell types and tissues, such 
as: bone, cartilage and connective tissue of the head 
and neck; melanocytes; endocrine cells (thyroid gland 
C-cells, adrenal medulla); neurons and glia of the pe-
ripheral nervous system and others. Adult NC-MSCs 
are identified and isolated from many tissues and 
organs of the adult mammalian organism, including 
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humans [5]. It is shown that adult NC-MSCs retain 
the ability to directed multilineage differentiation into 
the main derivatives of the neural crest, similar to their 
embryonic counterparts [5]. In a number of studies 
on animal models the positive effect of adult NC-MSCs 
has been shown to restore the critical size of calvarial 
bone defects [6], stimulation of peripheral nerve re-
generation [7, 8], spinal nerve dorsal root avulsion [9] 
and spinal cord injury treatment [10].
One of the most attractive from the possible 
sources of adult NC-MSCs is the hair follicle (HF) due 
to the minimal invasiveness of the biopsy. For the first 
time, adult NC-MSCs were identified and isolated 
from mouse whisker follicles [11]. The method was 
based on the use of the explant technique and a mi-
gratory behavior of NC-MSCs. Later, adult NC-MSCs 
were obtained from skin HFs of mice and another 
species, including human [12–14]. For the production 
of human adult NC-MSCs, several techniques have 
been proposed: the culturing of HF explants plucked 
[15] or dissected from a skin biopsy [16], selection 
of cells from dissociated HFs based on surface 
markers by fluorescence activated cell sorting or im-
munomagnetic separation [17], culturing dissociated 
cells under sphere-forming conditions, etc [18]. Each 
of these techniques has its advantages and disadvan-
tages. However, even when using similar techniques 
for the production of human adult NC-MSCs, the re-
sulting populations differ in the expression of a num-
ber of key neural crest markers such as Sox10 and 
p75 (CD271, LNGFR) [15, 16]. Also, minimal data are 
available on the expression of surface markers by cul-
tured human adult NC-MSCs and on the possibility 
of their large-scale expansion to obtain the significant 
cell number required for clinical applications.
Thus, the goal of our work was to obtain human 
adult NC-MSCs cultures from the minimal skin biopsy 
of patients, to master their large-scale expansion, and 
to determine their phenotype and functional properties.
MATERIALS AND METHODS
All procedures for obtaining human skin biopsies, 
cell isolation and culturing were performed with writ-
ten informed consent of patients and in accordance 
with the laws of Ukraine. The study protocol and the 
local clinical protocol were approved by the Bio-
ethics Committee of the Medical company ilaya®. Cell 
culturing was carried out in the GMP/GTP-compliant 
biotechnological laboratory ilaya.regeneration (Li-
cense to operate the Banks of human cord blood, 
other tissues and cells, issued by the Ministry of Health 
of Ukraine AE No. 186342 from 11.07.2013).
The donor skin specimens were obtained from 
3 patients with spinal cord contusion injuries and 
2 patients with critical sized calvarial bone defects.
Donors and cells screening. All patients/
donors (peripheral blood — ELISA, PCR) and cell 
cultures (PCR) were screened for absence of human 
immunodeficiency virus type 1/2, hepatitis B virus, 
hepatitis C virus, herpes simplex virus type 1/2, 
cytomegalovirus, Epstein — Barr virus, Treponema 
pallidum and Mycoplasma ssp. The cell cultures were 
also tested for common mycoplasma contamination 
by PCR with Mycoplasma Test Kit I (AppliChem, Ger-
many). The normal karyotype of cultured cells was 
confirmed by GTG-banding method.
The isolation and culturing of NC-MSCs from 
human HF. The NC-MSCs cultures were obtained 
from HF explants according to M. Sieber-Blum 
method [11] in our modification. One skin specimen 
per donor was obtained under local anesthesia with 
use of a dermal punch (diameter 5 mm). The biopsies 
were placed in DMEM:F12 transport medium (Sigma, 
USA) supplemented with 15 mM HEPES and antibi-
otic/antimycotic solution. Skin specimen was minced 
and incubated overnight at 4 °C in Dispase II solution 
(0.4 U/ml) (Sigma-Aldrich, USA). The next day, under 
the control of Stemi 2000 stereomicroscope (Carl 
Zeiss, Germany), a layer of epidermis was removed 
using tweezers, and then HFs were isolated. HFs 
were explanted over a thin layer of collagen gel in two 
35 mm Petri dishes and incubated for 40 min. After 
attachment, the explants were covered with a growth 
medium and cultured in a multi-gas incubator Binder 
CB 210 (Binder, Germany) at 37 °C with 5% CO2 and 
5% O2 and a saturating humidity. For expansion 
of adult NC-MSCs, the following growth medium 
was used: αMEM w/o nucleosides (Sigma-Aldrich, 
USA), 5% FBS (Sigma-Aldrich, USA), 5 ng/ml bFGF 
(Gibco, UK), 10 ng/ml EGF (Gibco, UK), 1% ITS 
supplement (Gibco, UK), 2 mM stable L-glutamine 
(BioWest, France) and 1% antibiotic/antimycotic 
solution (BioWest, France). The primary culture was 
passaged on Day 14–20 into the collagen-coated 
T25 flasks (SPL, Korea). Starting at P2, the cells were 
seeded into the collagen-coated 875 cm2 surface 
area multi-flasks (Corning, USA) with a seeding den-
sity of 1000 cells/cm2. The cultures were subcultured 
using 0.01% trypsin solution in 0.53 mM Na2EDTA 
solution (Sigma-Aldrich, USA). The cell population 
doubling number (PDN) and cell population doubling 
time (PDT) were calculated according to the following 
standard formulas [19]:
PDT = T / 3.31 lg (Xk / X0);
PDN = 3.31 lg (Xk / X0),
where Xk — number of obtained cells; X0 — number 
of plated cells; T — cell culture time.
Colony forming units (CFU) assay and self-re-
newal ability. To assess the clonogenic potential, the 
NC-MSCs at the last passage (P) were seeded in num-
ber of 100-300 cells in collagen-coated 100 mm Petri 
dishes (SPL, Korea) in growth medium supplemented 
with 20% FBS and cultured for 14 days. The cells were 
either fixed and stained for CFU assay or subcloned 
for self-renewal analysis. The effectiveness of colony 
formation (plating efficiency) was calculated using the 
standard formula [19]:
PE, % = (no. colonies counted / no. cells  
inoculated) × 100,
where PE — plating effciency.
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Transfer of the clonal colony (subcloning) was car-
ried out using cloning cylinders (Sigma-Aldrich, USA). 
The cells were cultured for 14 days, fixed and stained 
for analysis for formation of secondary CFUs.
Analysis of the expression of cell surface and 
intracellular markers by flow cytometry. NC-
MSCs immunophenotype was determined at the final 
passage using a flow cytometer-sorter BD FACSAria 
(BD Biosciences, USA) with fluorochrome-conjugated 
mouse monoclonal antibodies to CD34, CD45, CD56, 
CD73, CD90, CD105, CD140a, CD140b, CD146, 
CD166, CD271 and Nestin (BD Pharmingen, USA) 
in accordance with the manufacturer’s instruc-
tions. For detection of Sox10, primary unconjugated 
mouse monoclonal antibodies (Novus, USA) and 
secondary Alexa-647 donkey anti-mouse monoclonal 
antibo dies (Thermo Fisher, USA) were used. For the 
detection of CD349 (Frizzled-9), primary unconju-
gated rabbit antibodies (Bioss, USA) and secondary 
Alexa-647 donkey anti-rabbit monoclonal antibodies 
were used. For intracellular staining cells were fixed 
with Cytofix solution, permeabilized and stained 
in PhosFlow buffer (all — BD Biosciences, USA) ac-
cording to the manufacturer’s instructions. The as-
say was performed using BD FACS Diva 6.1 software 
(BD Biosciences, USA). Histogram generation was 
performed with use of software Cyflogic v.1.2.1 (CyFlo 
Ltd., USA).
Directed adipogenic differentiation. NC-MSCs 
were seeded with density of 40•103 cells/cm2 in growth 
medium and the following day were switched to the 
following differentiation medium: DMEM-HG (4.5 g/l) 
supplemented with 10% FBS, 1 µM dexamethasone, 
200 µM indomethacine, 500 µM isobutylmethylxan-
thine, 5 µg/ml insulin (all — Sigma-Aldrich, USA) and 
5% horse serum (BioWest, France). The medium was 
changed 2 times a week. The duration of differentia-
tion was 14 days.
Directed osteogenic differentiation. NC-MSCs 
were seeded at 20•103 cells/cm2 in growth medium 
and the next day switched to a following differentiation 
medium: DMEM low glucose (1.0 g/l) with 10% FBS, 
100 nM dexamethasone, 10 mM β-glycerophosphate 
and 50 µg/ml ascorbate-2-phosphate (all — Sigma-
Aldrich, USA). The medium was changed 2 times 
a week during 21 days.
Directed neuronal differentiation. NC-MSCs 
were seeded at a concentration of 50•103 cells 
on coated by poly-L-lysine (Sigma-Aldrich, USA) 
and laminin (Gibco, UK) coverslips in 4 well plates 
(SPL, Korea) in growth medium. The following 
day cells were switched to the following differen-
tiation medium: Neurobasal medium (Gibco, UK), 
2% B27 supplement (Gibco, UK), 1% N2 supple-
ment (Gibco, UK), 5 µM ec32 synthetic retinoid 
(AMSBIO, UK), 1 µM forskolin (Sigma-Aldrich, USA), 
20 ng/ml NGF (PeproTech, USA), 20 ng/ml BDNF 
(PeproTech, USA), 20 ng/ml GDNF (PeproTech, USA) 
and 20 ng/ml IGF (Gibco, UK). The duration of diffe-
rentiation was 14 days.
Differentiation in the glial direction (Schwann 
cells). NC-MSCs were seeded at a concentration 
of 50•103 cells on coated by poly-L-lysine (Sigma-
Aldrich, USA) and laminin (Gibco, UK) glass coverslips 
in 4 well plates (SPL, Korea) in growth medium. The 
following day cells were switched to the following dif-
ferentiation medium: 1:1 of Neurobasal (Gibco, UK) 
and DMEM:F12 (Gibco, UK) media, 2% B27 supple-
ment (Gibco, UK), 1% N2 supplement (Gibco, 
UK), 1 µM ec32 synthetic retinoid (AMSBIO, UK), 
5 µM forskolin (Sigma-Aldrich, USA), 20 ng/ml Neu-
regulin-1 (Gibco, UK), 10 ng/ml PDGF-BB (PeproTech, 
USA) and 20 ng/ml IGF (Gibco, UK). The duration 
of differentiation was 14 days.
Cytochemistry. For CFU staining, the cell colonies 
were fixed for 20 min with cold ethanol and azure-eosin 
stained by Romanowsky (Makrokhem, Ukraine) for 
20 min. To confirm the osteogenic and adipogenic dif-
ferentiation, the cells were fixed for 20 min in 10% for-
malin (Makrokhem, Ukraine), washed with phosphate 
buffered saline (Sigma-Aldrich, USA) and stained for 
20 min with 2% solution of Alizarin Red S (pH 4.1; for 
detecting calcified extracellular matrix) and 0.5% 
solution of Oil Red O (for staining of neutral lipids) 
respectively (all — Sigma-Aldrich, USA).
Immunocytochemistry. The following primary 
antibodies were used for immunocytochemical stain-
ing: rabbit polyclonal against S100β (Invitrogen, 
USA), p75 (CD271) and Sox2 (all — BioLegend, USA); 
mouse monoclonal against Sox10 (R&D, USA), Nestin 
(Santa Cruz, USA), β-III-tubulin (Sigma-Aldrich, USA). 
Secondary antibodies were donkey anti-mouse and 
donkey anti-rabbit Alexa-488 or Alexa-647 conju-
gated (Thermo Fisher, USA). The cells were fixed for 
20 min with cold 4% paraformaldehyde, permeabilized 
with intracellular staining for 15 min with 0.1% Triton 
X-100, blocked for 30 min in phosphate buffered saline 
with 0.1% Tween-20, 1% BSA, 5% FBS. The slides 
were incubated with primary antibodies overnight 
at 40 °C and with secondary antibodies for 1 hour 
at room temperature.
Microscopy. Intravital microscopy and ex-
amination of cytological slides were carried out with 
inverted Axio Observer A1 microscope equipped 
with an AxioCam ERc 5s digital camera and ZEN 
2012 software. Confocal microscopy was performed 
with Zeiss LSM 510 META microscope (all — Carl Zeiss, 
Germany).
Statistics. The data are presented as Mean and 
Standard Deviation (M ± SD).
RESULTS AND DISCUSSION
We successfully obtained and expanded up to the 
therapeutic dose the adult NC-MSCs from all 5 donors. 
The characteristics of donors, number of explanted 
HF and terms of growth of primary cell cultures are 
presented in Table 1. On average, 15.8 ± 4.5 HFs were 
obtained from one skin sample of 5 mm in diameter. 
It should be noted that part of HFs (1–5 per culture, 
16.4 ± 7.1% of explanted HFs) was detached, despite 
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the use of a thin layer of collagen hydrogel as a sub-
strate. Outgrowth of human NC-MSCs was observed 
from more than half of the explanted HFs. Herewith, 
most of the HFs revealed the mixed outgrowth of NC-
MSCs and keratinocytes (34.9 ± 11.6% HFs vs 25.3 ± 
8.8% HFs with pure outgrowth of NC-MSCs). In our 
case, the emigration and proliferation of NC-MSCs 
from explants have started 5–10 hours, the culture 
time of the primary culture was 16.2 ± 2.5 days on the 
average and 104 NC-MSCs were obtained from a single 
HF, which corresponds to the data published by other 
groups [15, 16]. Fig. 1, a shows the HF explant with 
a pure outgrowth of NC-MSCs just before subcultur-
ing. Fig. 1, b shows the NC-MSCs with characteristic 
stellate morphology and migratory behavior. For fur-
ther expansion of pure cultures, the NC-MSCs were 
successfully separated from the primary keratinocyte 
impurity by a differential trypsinization technique while 
subculturing. The use of 0.01 trypsin solution allowed 
the NC-MSCs to be effectively collected, while dense 
colonies of keratinocytes remained attached to the 
substrate. The absence of NC-MSCs contamination 
by keratinocytes at P1 was verified by immunostain-
ing for pan-cytokeratin, which gave a negative result 
(data not shown).
Beginning the P1 in our culture conditions, a stable 
rapid growth of NC-MSCs was established. Cell growth 
parameters at P1-P3 are shown in Table 2. Thus, 
when the seeding concentration was in the range 
of 500–1300 cells per 1 cm2, the cultures reached 
70–100% confluency within 5–7 days, and been sub-
cultured every week. At the same time, an average 
6.04 ± 0.35 PDN took place within a passage, with 
averaged PDT 27.90 ± 1.58 hours. These parameters 
during the early passages (P1–P3) showed weak 
differences both within the culture from one donor 
at different passages, and between donors.
Determination parameters of safety and efficacy 
of human cell-based medicinal product mean the sta-
bility of the cell karyotype after in vitro expansion and 
the number of CFU. Cultures from all donors at the end 
of expansion were subjected to cytogenetic analysis 
and showed normal karyotype. Analysis of the CFU fre-
quency showed that after large-scale expansion of cul-
tures of human adult NC-MSCs from HF, a significant 
number of cells maintained the clonogenic potential 
and CFU frequency was 25.9 ± 7.7%. An important 
feature of stem cells is the ability to self-renew. To as-
sess the self-renewal, five CFUs per each donor were 
subcloned. In all cases the formation of seconda ry 
colonies was detected. Thus, human adult NC-MSCs 
from HF retain their clonogenic potential and ability 
to self-renew after large-scale expansion under our 
cell culture cultural conditions.
We also examined the phenotype of the obtained 
cultures by flow cytometry and immunocytochemistry 
for key markers of neural crest (Sox10, p75), com-
mon markers of stem cells (nestin, Sox2 and CD34), 
markers of mesenchymal stem/stromal cells (CD73, 
CD90 and CD105), receptors for some growth factors 
Fig. 1. Adult NC-MSCs from HF: a — explant of HF with pure outgrowth of NC-MSCs just before passaging. Phase contrast, scale 
bar — 200 µm; b — characteristic stellate morphology of NC-MSCs. The small rounded bright cells — NC-MSCs in mitosis. Phase 
contrast, scale bar — 50 µm
Table 1. Parameters of primary cell cultures (P0)
Donor 
ID Age, sex and condition
Total number 
of explanted HFs
HFs with NC-
MSCs out-
growth, n (%)
HFs with mixed 
outgrowth, n (%)
HFs with kera-
tinocytes out-
growth, n (%)
Detached 
HFs, n (%)
Culture 
time, days Cell yield
1 24 years, male, SCI 14 3 (21.4) 7 (23.8) 2 (23.8) 1 (23.8) 14 29,000
2 25 years, male, SCI 9 2 (33.3) 3 (23.8) 3 (23.8) 1 (23.8) 20 16,000
3 31 years, male, SCI 17 6 (35.3) 4 (23.8) 4 (23.8) 3 (23.8) 14 52,000
4 27 years, male, bone 
defect 21 3 (14.3) 6 (28.6 5) 7 (33.3) 5 (23.8) 16 31,000
5 62 years, female, bone 
defect 18 4 (22.2) 5 (23.8) 5 (23.8) 4 (23.8) 17 43,000
M ± SD 15.8 ± 4.5 3.8 ± 1.3(25.3 ± 8.8)
5.2 ± 1.3
(34.9 ± 11.6)
3.8 ± 2.4
(22.0 ± 9.2)
2.8 ± 1.8
(16.4 ± 7.1) 16.2 ± 2.5 34,200.0 ± 13,809.4
Note: SCI — spinal cord injury.
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(CD140a/PDGFRα, CD140b/PDGFRβ and CD349/
Frizzled-9), adhesion molecules (CD56/NCAM, 
CD146/MCAM and CD166/ALCAM), and markers 
of hematopoietic (CD45) and antigen-presenting cells 
(HLA-DR). Representative flow cytometry histograms 
of cell culture from donor # 2 are shown in Fig. 2. Sum-
mary data for all donors are presented in Table 3.
All expanded cultures of NC-MSCs contain more 
than 90% Sox10+ and Nestin+ cells, but the number 
of cells expressing p75 (CD271) varied significantly 
from 45.9 to 93.8% positive cells (73.32 ± 18.39%). 
Interesting, NC-MSCs homogeneously expressed 
the key mesenchymal stem/stromal markers CD73, 
CD90 and CD105 [2, 3]. All these markers were 
presented on more than 90% cells in average. Also 
in average more than 90% of the cells were positive 
for CD140b, CD166 and CD349. More heterogeneous 
cultures were by expression of CD140a (67.68 ± 14.26) 
and CD146 (87.92 ± 8.42). Adult NC-MSCs were nega-
tive for hematopoietic markers CD34 and CD45 (the 
number of positive cells did not exceed 1%). Some-
times a small number of CD56+ (up to 7.8%) and HLA-
DR+ (up to 4.2%) cells was noted.
Taking into account the key role of Sox10, 
p75 (CD271) and nestin in the determination of the 
identity of NC-MSCs [4, 5], we also examined them 
using the immunocytochemical analysis. Additionally, 
Sox2 has also been studied because of its important 
role in stemness maintenance and functional prop-
erties of NC-MSCs [20, 21]. As shown in Fig. 3 and 
Fig. 2. Representative results of NC-MSCs phenotype analysis by flow cytometry
Table 2. Parameters of cell cultures at P1–P3
Donor ID
Growth sur-
face area, 
cm2
Plating 
density, 
cell/cm2
Cell yield, 
106 PDN PDT, hours
Cumula-
tive PDN
Average PDT, 
hours
CFU frequency 
at final  
passage, %
Secondary CFU 
formation
(self-renewal)
Karyotype
1 P1 25 1160 1.73 5.9 28.6 11.7 28.8 20.3 ± 5.9 + Normal, 23XYP2 875 1000 49.00 5.8 29.0
2 P1 25 640 1,85 6.8 24.6 13.0 26.0 36.7 ± 5.7 + Normal, 23XYP2 875 1000 63.00 6.1 27.3
3 P1 50 1040 4,33 6.4 26.4 12.5 26.8 30.7 ± 2.1 + Normal, 23XYP2 875 1000 64.8 6.2 27.1
4 P1 25 1240 2.10 6.1 27.7
18.2 27.8 24.3 ± 3.5 + Normal, 23XYP2 875 1000 53.40 5.9 28.4
P3 2625 1000 193.50 6.2 27.2
5 P1 50 860 1.93 5.5 30.7
17.1 29.5 17.7 ± 5.5 + Normal, 23XXP2 875 1000 56.00 6.0 28.1
P3 3500 1000 178.00 5.6 29.7
M ± SD n/a n/a n/a 6.04 ± 0.35 27.90 ± 1.58 n/a 27.78 ± 1.43 25.9 ± 7.7 n/a n/a
Note: n/a — not applicable.
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Fig. 4, most of the cells in the culture were Sox10+p75+ 
and Sox2+Nestin+, which confirms the flow cytometry 
data. As described earlier, for human adult NC-MSCs 
from HF [16, 22] the Sox10 showed a characteristic 
nuclear- cytoplasmic localization, consistent with 
its role as a transcription factor and active nucleo-
cytoplasmic shuttle protein [23]. Sox2 had predomi-
nantly nuclear localization, which is characteristic of its 
function as a transcription factor. Nestin and p75 also 
showed the characteristic staining for the intermedi-
ate filament protein and intracellular domain of growth 
factor receptor respectively.
In addition to the ability to self-renew another 
important functional property of stem cells is the 
abili ty to multilineage differentiation. Considering that 
HF from the head area were used in our study, these 
NC-MSCs were derived from the cranial neural crest 
during the embryonic development. Cranial neural 
crest gives rise to the widest variety of tissues and cell 
types from all the axial domain of neural crest [5]. So, 
in addition to melanocytes, neurons and glia of the 
peripheral nervous system, the cranial neural crest 
gives rise to ectomesenchyme, from which a part of the 
bone, cartilage and connective tissue of the head and 
neck is formed. Based on this, we verified the identity 
of the obtained adult NC-MSCs by ability to differenti-
ate into both mesenchymal cell types (adipocytes and 
osteoblasts), and into neurons and Schwann cells. 
Adult NC-MSCs were cultured for 14 days in an ad-
ipogenic induction medium and have successfully 
differentiated into the adipocytes containing lipid vacu-
oles (Fig. 5, a). When cultured in osteogenic medium 
during 14 days, NC-MSCs were converted to alkaline 
phosphatase-positive osteoblasts (Fig. 5, b) and 
after 21 days the mineralized extracellular matrix was 
produced (Fig. 5, c). When NC-MSCs were cultured 
in the presence of a synthetic analogue of retinoic acid 
and neurotrophins (NGF, BDNF and GDNF), they were 
converted into the homogeneous population of neu-
ronal β-III-tubulin positive cells with spherical or oval 
soma and long thin processes (Fig. 5, d). Under the 
influence of neuregulin-1, PDGF-BB and the activation 
of cAMP signaling by forskolin, NC-MSCs differenti-
ated into S100β-positive cells with the characteristics 
for Schwann cells bipolar morphology (Fig. 5, e).
As mentioned in the Introduction, the existence 
of adult NC-MSCs in the bulge region of HF was first 
shown by M. Siber-Blum using whisker follicles from 
Wnt1-Cre transgenic mice for tracing developmental 
origin of this cell population from neural crest [11]. In the 
study NC-MSCs obtaining was based on the migratory 
behavior of this cell type. NC-MSCs emigrated and 
began to proliferate rapidly while culturing the explants 
of the bulge region on collagen substrate in a special 
neural crest cell growth medium. Mouse NC-MSCs 
from bulge region of HF were Sox10+Nestin+ and had 
the ability for directed differentiation into neurons, 
Schwann cells, melanocytes, smooth muscle cells and 
chondrocytes. In parallel, Fernandes et al. using the 
same Wnt1-Cre transgenic mouse line reported the 
isolation of another cell population of the neural crest 
origin from derma of facial skin, which was called skin-
Table 3. Phenotype of NC-MSCs at last passage (P2–P3) by flow cytometry
Donor ID Sox10 CD271 (p75) Nestin CD73 CD90 CD105 CD140a CD140b CD146 CD166 CD349 CD34 CD45 CD56 HLA-DR
1 95.3 65.3 97.8 99.5 98.7 96.3 62.8 96.9 82.3 91.5 90.7 0,3 0,6 1,5 1,2
2 99.9 82.5 99.1 99.9 99.5 99.2 91.4 98.4 96.8 89.9 98.3 0,9 0,2 0,0 1,1
3 96.2 79.1 92.1 95.3 92.7 89.9 58.9 87.3 77.9 87.7 92.3 0,9 0,2 7,8 0,9
4 98.3 93.8 97.5 99.2 96.8 98.5 55.6 94.9 96.3 98.8 96.5 1,2 0,5 3,5 0,4
5 91.8 45.9 88.7 96.9 97.3 96.4 69.7 81.7 86.3 97.5 87.5 0,4 0,1 2,4 4,2
M ± SD 96.30 ± 
3.09
73.32 ± 
18.39
95.04 ± 
4.44
98.16 ± 
1.98
97.00 ± 
2.63
96.06 ± 
3.09
67.68 ± 
14.26
91.84 ± 
7.10
87.92 ± 
8.42
93.08 ± 
4.84
93.06 ± 
4.37
0.74 ± 
0.38
0.32 ± 
0.22
3.08 ± 
2.90
1.56 ± 
1.51
Fig. 4. Immunocytochemical analysis of NC-MSCs for p75 (CD271) 
(red) and Sox10 (green) expression. Scale bar — 20 µm
Fig. 3. Immunocytochemical analysis of NC-MSCs for 
Sox2 (green) and Nestin (red) expression. Scale bar — 20 µm
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derived precursors cells (SKPs) [24]. It turned out that 
the tissue niche for SKPs is dermal papilla of HFs from 
facial skin and whisker follicles [24]. The procedure for 
SKPs obtaining was based on their ability to grow in the 
form of spheres (resembling neurospheres) under 
serum-free and non-adherent conditions. At the same 
time, SKPs showed a similar differentiation potential 
to NC-MSCs from the bulge region of HF. However, 
they were Sox10 and p75 negative, but they expressed 
other characteristic neural crest markers — Nestin, 
Slug, Snail, Twist and Sox9 [24]. Later, a more in-depth 
analysis of the localization of NC-MSCs in whisker fol-
licles and HF from dorsal and ventral skin of mice has 
been made with use of Wnt1-Cre, Ht-PA-Cre, Sox10lacZ, 
Dhh-Cre and Dct-Cre transgenic mouse lines [12]. 
In those paper it was confirmed that many structures 
of whisker follicle derived from neural crest, harbor 
cells with stem cells-like properties and this cells linked 
to mesenchymal, glial and melanocyte lineages. Such 
structures in whisker follicles are: bulge region, dermal 
sheath, capsule, dermal papilla, nerve terminals and 
regions above sebaceous glands. Analysis of mouse 
HF from back skin showed that neural crest-derived 
cells are localized in the bulge region and in the bulb 
above the dermal papilla [12]. The dermal papilla of the 
back skin itself does not originate from the neural 
crest. Lineage tracing analysis showed that neural 
crest-derived cells in trunk HFs are linked to glial and 
melanocyte lineages. Using somewhat different from 
Fernandes et al. [24] growth conditions, the authors 
obtained spheres from mouse back skin and human 
skin (face and thigh) samples [12]. Analysis of the cell 
composition of the spheres obtained from transgenic 
mice showed that they are formed by cells that have 
neural crest origin. It should be noted, 100% mouse 
and human skin-derived spheres contains p75+ and 
Sox10+ cells. In mouse spheres 67.0 ± 10.5% of all 
cells expressed p75; 76.6 ± 4.5% of all cells expressed 
Sox10; and 58.6 ± 10.5% of all cells were double posi-
tive for p75 and Sox10. Then, 15.0 ± 6.2% of all sphere 
cells were negative for these markers, which indicates 
cell heterogeneity in the composition of spheres, which 
may be associated with spontaneous cell differen-
tiation. Similar to mouse spheres, all human spheres 
contained p75/Sox10 double positive cells, which 
accounted for > 60% of all cells. However, the cells 
were negative for other neural crest markers, such 
as Sox9 and HNK-1 (CD57). Both mouse and human 
neural crest-derived cells from HF showed the ability 
to multilineage directed differentiation into the main 
derivatives of the neural crest: peripheral neurons, 
Schwann cells, melanocytes, adipocytes, chondro-
cytes and smooth muscle cells [12].
Thus, lineage tracing experiments using trans-
genic mouse lines showed that the HF contains various 
Sox10 and p75 positive and negative cells of neural 
crest origin with multilineage differentiation potential 
and stem cell-like properties.
Fig. 5. Detection of NC-MSCs directed multilineage differentiation: a — adipogenic differentiation, Oil Red O staining of lipid vacuo-
les (red). Scale bar — 50 µm; b — osteogenic differentiation, BCIP/NBT staining for ALP activity (dark blue). Scale bar — 100 µm; 
c — osteogenic differentiation, Alizarin Red S staining of mineralized extracellular matrix (red). Scale bar — 200 µm; d — neuronal 
differentiation, immunocytochemical detection of β-III-tubulin (green). Scale bar — 20 µm; e — glial differentiation (Schwann cells), 
immunocytochemical detection of S100β protein (green). Scale bar — 20 µm
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The existence of NC-MSCs in the bulge region 
of human HF was also confirmed by other authors and 
several variants of growth media and methods for their 
isolation were proposed for the isolation of NC-MSCs 
from dissociated HFs or skin samples and their growth 
under the floating sphere conditions [14, 17, 18].
Although it has been shown in [12] that the human 
skin-derived spheres could be serially subcultured for 
more than 3 months and generates more than 109 cells 
during this time, the disadvantage of human NC-MSCs 
culturing under sphere conditions is its high cost and 
relatively low cell growth rate.
For these reasons, attempts have been made 
to modify the original M. Siber-Blum protocol to obtain 
NC-MSCs cultures from human HF explants. In one 
of the first reports it was shown that NC-MSCs do not 
provide cell emigration and growth in a monolayer when 
human HF explants culturing, but only form spheroid 
structures attached to the bulge area of HFs [14, 25]. 
Later, the group of M. Siber-Blum and other authors 
reported the successful adaptation of the explant 
method to the production of human NC-MSCs cultures 
[15, 16, 22]. At the same time, several critical mo-
ments and shortcomings in the use of this technique 
were revealed. The most critical and time-consuming 
step in adult NC-MSCs obtaining is the establishment 
of primary cultures [15, 16, 22]. The main difficulties 
in obtaining primary cultures of human adult NC-MSCs 
from HF explants are the detachment of HFs, the 
absence of outgrowth of NC-MSCs and overgrowth 
of keratinocytes [15, 16]. Also there are contradic-
tory data on NC-MSCs morphology (from spindle-like 
to stellate) and markers expression [15, 16]. It can 
be due to both the use of different culturing conditions 
and the methods of extraction of HFs from a skin (dis-
sected vs plucked) and different skin regions. It should 
be noted that the equivalence of the use of dissected 
vs plucked human HFs for NC-MSCs isolation and 
the identity of the resulting cell populations remain 
an open question. There is an opinion that the bulge 
region is damaged in plucked HFs. As a result, various 
phenotypes of adult NC-MSCs derived from plucked 
and dissected HF have been reported. So, in [15], 
the NC-MSCs from plucked HFs were Sox10 nega-
tive, but positive for common used neural crest 
markers, like Nestin, Slug, AP-2α and Sox9. Whereas 
NC-MSCs the resulting from the dissected HFs were 
Sox10+Sox2+Nestin+ by immunocytochemistry [16, 
22]. There was also expression of Slug, Twist and 
P75 genes detected by qPCR [16, 22].
In our study, to improve the reliability and effec-
tiveness of the procedure for NC-MSCs obtaining, 
we modified the original protocol of M. Siber-Blum [11] 
in the following points: 1) use of Dispase enzyme for 
separation of the epidermis and facilitation of the HFs 
dissection procedure; 2) use of a thin layer of collagen 
hydrogel as an adhesive coating for the attachment 
of HF explants; 3) maintenance of adhered explants 
in the primary culture until the moment of subculturing. 
In fine, these minor modifications have significantly 
improved cell isolation and culturing protocol, which 
will be discussed below.
So, we managed to significantly reduce the fre-
quency of HF explants detaching to less than 20%. 
For comparison, when using the poly-D-lysine treated 
plastic surface, more than 40% of explants of HFs [15] 
are detached.
Regardless of the cell culture conditions used, 
it has not yet been possible to obtain 100% outgrowth 
of NC-MSCs from all adhered HFs and the reasons for 
this remain unclear. A possible link can exist with the 
growth phase of HF. So in [16], it is shown that more 
often NC-MSCs emigrated from explanted HFs been 
in early or late anagen growth stages. On the other 
hand, in [17] it has shown the possibility of NC-MSCs 
obtaining both from HFs in the anagen stage and 
the telogen stage. In various studies, the outgrowth 
of NC-MSCs was from 20% in [25] to 34% in [15] 
or almost for 50% of explants [16]. Clewes et al. [16] 
were noted that more often emigration of human 
NC-MSCs was observed from the explants of HFs with 
preserved dermal sheath — 45.3 ± 13.0%. NC-MSCs 
did not emigrate from the separately cultured dermal 
sheath of HFs and emigrated only from 6.3 ± 6.3% HFs 
without dermal sheath. Thus, the role of the dermal 
sheath is probably to preserve the bulge region unaf-
fected (intact, uninjured) during the extraction and 
isolation of HFs.
Keratinocytes outgrowth from human HF explants 
is a common problem [15, 16]. Interestingly, the emi-
gration of keratinocytes from the mouse bulge region 
of whisker follicles is observed much later than the 
emigration of NC-MSCs [11], or can be excluded alto-
gether by using a selective growth medium [26]. At the 
same time, keratinocytes outgrowth is often observed 
when culturing of rat bulge whisker follicle explants 
(our unpublished observations) or human HF explants. 
So, in [15] reported the keratinocytes outgrowth was 
from 33–100% explanted HFs, which is comparable 
to our data. Further progress in this direction may 
be related to the development of a selective growth 
medium, although according to our observations, 
keratinocytes proliferate in the primary culture of ex-
planted HFs even in the absence of EGF in the growth 
medium. It should be noted that the problem of con-
tamination of NC-MSCs cultures by keratinocytes with 
further expansion can be successfully solved using the 
technique of differential trypsinization, as it was made 
in our presented work.
As for the phenotype of adult NC-MSCs obtained 
during the large-scale expansion, it is comparable 
to that described for cultures obtained from dis-
sected human HFs [16, 17, 22] and differs from that 
described for cultures obtained from plucked human 
HFs [15]. The reason for this can be both the HF isola-
tion methods and slightly different culture conditions. 
A weak modification of growth conditions can either 
influence the expression of neural crest markers 
(like Sox9, Sox10 or p75), or give selective benefits 
to different cell populations with neural crest origin, 
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which contains in HF. So, Sox10 and p75 are the first 
markers that distinguish neural crest cells immedi-
ately after their induction from Sox2+ neuroepithelium 
of neural tube [27]. And although these markers are 
used for prospective isolation and/or for the confir-
mation of neural crest origin of cells from different 
tissues of the adult organism, their expression is not 
always observed in adult neural crest-derived cells, 
especially in ectomesenchymal cells of the craniofa-
cial region [4, 5]. Thus, expression of Sox10 by neural 
crest-derived cells at later stages of development 
and in adulthood can be related to their broader 
differentiation potential while retaining the ability 
to acquire neuronal, glial and melanocyte fates [28, 
29]. Whereas ectomesenchymal cells with differen-
tiation potential restricted to mesenchymal cell fate 
can be Sox10 negative [4, 5]. The p75 function and 
the heterogeneity of its expression in the populations 
of adult neural crest-derived cells remain largely not 
understood. A comparative study of the prolifera-
tion and differentiation potential of Sox10+p75+ and 
Sox10+p75− cells is needed. Concerning the double 
negative Sox10−p75− cells, we assume that they can 
be progenitors with the development of potential 
restricted to mesenchymal cell fate [30]. This is sup-
ported by the preservation of the expression of CD73, 
CD90 and CD105 (markers of mesenchymal stem/
stromal cells) by Sox10−p75− cells.
An important point is that the NC-MSCs expanded 
by our protocol are Sox2+. Sox2 is one of the main fac-
tors of pluripotency and a marker of neural stem/pro-
genitor cells of central nervous system. Although at the 
time of induction, neural crest cells are Sox2 negative 
[27, 30], its expression appears in them at later stages 
of development and is associated with the preserva-
tion of multipotency and ability to neurogenesis [4, 5, 
20, 30]. Detection of a small number of CD56+ cells 
may indicate spontaneous neuronal differentiation 
of NC-MSCs during expansion. It is important to note 
that in addition to neurogenesis, Sox2+ NC-MSCs 
play a key role in skin wound healing and in reparative 
regeneration process regulation as shown in the ex-
periments with use of transgenic mouse lineages [21].
Also important findings in our study are the ex-
pression on the adult NC-MSCs of such receptors 
for growth factors as CD140a (PDGFRα), CD140b 
(PDGFRβ), CD349 (Frizzled-9) and CD166 (ALCAM). 
Expression of CD140a and CD140b by NC-MSCs can 
be associated with several key aspects of their biology, 
such as differentiation into Schwann cells, or their ac-
tivation after tissue damage through platelet-released 
PDGFs. The role of PDGF proteins in NC-MSCs biology 
should also be studied in more details in the light of the 
possible use for cell xeno-free expansion of a platelet 
lysate which contains them in large quantities. Con-
cerning CD349 expression, this indicates the need 
for Wnt-signaling studying in adult NC-MSCs biology. 
It is known that in the early stages of development the 
self-renewal of NC-MSCs is supported by the com-
bined action of Wnt and BMP signaling [31]. The role 
of these factors in the proliferation, self-renewal and 
differentiation of adult NC-MSCs is poorly understood. 
CD166 expression may indicate the presence of an im-
munomodulatory properties in adult NC-MSCs. De-
tection of the minor population of HLA-DR+ cells can 
also be associated with the immunological functions 
of NC-MSCs. It is well known that bone marrow-de-
rived mesenchymal stem/stromal cells have the ability 
for inducible expression of HLA-DR after exposition 
to inflammatory signals. This aspect of adult NC-MSCs 
biology is not actually studied.
Thereof, our study shows for the first time the 
principal possibility of large-scale expansion of adult 
NC-MSCs from HF with preservation of their pheno-
type and basic functional properties. The therapeutic 
number of cells required for clinical use ranges from 
40•106 to 200•106 and can be obtained during one 
month of culturing. These terms theoretically allow 
us to consider the possibility of developing autolo-
gous medicinal products based on human NC-MSCs 
for the treatment of spinal cord injuries and traumatic 
peripheral nerve defects not only in the chronic but 
also in the subacute period. It is generally accepted 
that reconstructive surgery of damaged spinal cord 
and peripheral nerve cannot be carried out in the acute 
period, and the most favorable results are obtained 
when they are carried out in the subacute/early chronic 
period in comparison to late chronic period. Previ-
ously, despite the positive results of adult NC-MSCs 
application obtained in animal models of spinal cord 
injury and peripheral nerve defect, some skepticism 
is caused by the absence of protocols of obtaining 
a therapeutic dose in a short period of time (no more 
than 4–6 weeks). Next steps in this field should 
be further improvement of the isolation technique 
from HF, development of xeno-free conditions for adult 
NC-MSCs expansion and conducting of randomized 
clinical trials to assess the effectiveness of this cell 
type in the treatment of various diseases and defects 
of the neural crest-derived tissues and structures 
in comparison with existing “gold standards” of surgi-
cal or therapeutic treatment for these conditions.
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